DE3588043D1 - Cytokeratin-tumormarkierer und test zu deren nachweis. - Google Patents

Cytokeratin-tumormarkierer und test zu deren nachweis.

Info

Publication number
DE3588043D1
DE3588043D1 DE3588043T DE3588043T DE3588043D1 DE 3588043 D1 DE3588043 D1 DE 3588043D1 DE 3588043 T DE3588043 T DE 3588043T DE 3588043 T DE3588043 T DE 3588043T DE 3588043 D1 DE3588043 D1 DE 3588043D1
Authority
DE
Germany
Prior art keywords
detect
test
neoplastic
tumor marker
cytokeratin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3588043T
Other languages
English (en)
Other versions
DE3588043T2 (de
Inventor
Robert Cardiff
Paul Rossitto
Alan Brabon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
Original Assignee
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24273031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3588043(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of California Berkeley filed Critical University of California Berkeley
Application granted granted Critical
Publication of DE3588043D1 publication Critical patent/DE3588043D1/de
Publication of DE3588043T2 publication Critical patent/DE3588043T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
DE3588043T 1984-01-06 1985-01-03 Cytokeratin-tumormarkierer und test zu deren nachweis. Expired - Lifetime DE3588043T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56886284A 1984-01-06 1984-01-06
PCT/US1985/000010 WO1985003132A1 (en) 1984-01-06 1985-01-03 Cytokeratin tumor markers and assays for their detection

Publications (2)

Publication Number Publication Date
DE3588043D1 true DE3588043D1 (de) 1995-08-31
DE3588043T2 DE3588043T2 (de) 1996-03-21

Family

ID=24273031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3588043T Expired - Lifetime DE3588043T2 (de) 1984-01-06 1985-01-03 Cytokeratin-tumormarkierer und test zu deren nachweis.

Country Status (7)

Country Link
US (1) US4775620A (de)
EP (1) EP0167616B1 (de)
JP (5) JP2723203B2 (de)
AT (1) ATE125626T1 (de)
CA (1) CA1336171C (de)
DE (1) DE3588043T2 (de)
WO (1) WO1985003132A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR850552B (de) * 1984-03-07 1985-07-05 Du Pont
EP0242154B1 (de) * 1986-04-17 1993-03-03 Hybritech Incorporated Tumorassoziiertes Antigen
ATE92081T1 (de) * 1986-04-17 1993-08-15 Hybritech Inc Tumorassoziiertes antigen.
FR2606033B1 (fr) * 1986-10-31 1988-12-16 Cird Proteine cytoplasmique des cellules suprabasales de l'epiderme, anticorps capables de reconnaitre cette proteine, et lignees cellulaires hybrides capables de secreter de tels anticorps
FR2606034B1 (fr) * 1986-10-31 1989-06-02 Cird Nouvelle proteine de surface des cellules basales de l'epiderme, anticorps capables de reconnaitre cette proteine, et leur utilisation, et lignees cellulaires hybrides capables de secreter de tels anticorps
DE3815932A1 (de) * 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
US5660994A (en) * 1986-11-10 1997-08-26 Progen Biotechnik Gmbh Method of detecting tissue-specific, insoluble cytoskeletal proteins
DE3923951A1 (de) * 1989-07-19 1991-01-31 Boehringer Mannheim Gmbh Verfahren zum nachweis von leberzirrhose
US5411868A (en) * 1989-10-24 1995-05-02 Board Of Regents, The University Of Texas System Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy
DE3942999C2 (de) * 1989-12-27 1997-12-18 Progen Biotechnik Gmbh Verfahren zum Nachweis von malignen Erkrankungen
DE4023945A1 (de) * 1990-07-27 1992-01-30 Progen Biotechnik Gmbh Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern
SE470273B (sv) * 1990-09-24 1993-12-20 Idl Immunodeveloplab Ab Cytokeratinfragment, deras framställning och användning, framställning av monoklonala antikroppar och testkit för epitelialcancer
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
SE9500023L (sv) * 1994-05-17 1995-11-18 Beki Ab Sätt att detektera cancer
US5914238A (en) * 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6168779B1 (en) * 1997-09-16 2001-01-02 The Regents Of The University Of California Methods and kits for identifying ductal orifices
US6890311B2 (en) 1997-09-16 2005-05-10 The Regents Of The University Of California Methods for performing medical procedures within a breast duct
WO1999041613A1 (en) 1998-02-12 1999-08-19 Immunivest Methods and reagents for the rapid and efficient isolation of circulating cancer cells
GB9905817D0 (en) * 1999-03-12 1999-05-05 Oxford Glycosciences Uk Ltd Methods
DE50015293D1 (de) * 1999-04-13 2008-09-11 Wilex Ag Diagnostischer und therapeutischer Einsatz von Antikörpern gegen den Urokinase-Rezeptor
WO2001013117A2 (en) * 1999-08-13 2001-02-22 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2001046697A2 (en) * 1999-12-21 2001-06-28 Millennium Predictive Medicine Identification, assessment, prevention, and therapy of breast cancer
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
DE10130985B4 (de) * 2001-06-27 2004-03-18 B.R.A.H.M.S Ag Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente
KR100978348B1 (ko) 2001-08-31 2010-08-26 케라텍 리미티드 가용성 ｓ-술폰화 케라틴 유도체로부터의 생체고분자 필름, 섬유, 발포체 및 접착제 재료의 제조
AU2002327704A1 (en) * 2001-09-21 2003-04-01 Raven Biotechnologies, Inc. Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof
US7630403B2 (en) * 2002-03-08 2009-12-08 Texas Instruments Incorporated MAC aggregation frame with MSDU and fragment of MSDU
US7297342B2 (en) * 2002-06-10 2007-11-20 Keratec Limited Orthopaedic materials derived from keratin
WO2004047774A1 (en) * 2002-11-28 2004-06-10 Keratec Limited Personal care formulations containing keratin
US7767756B2 (en) * 2003-09-19 2010-08-03 Keraplast Technologies, Ltd. Composite materials containing keratin
WO2005043166A1 (ja) * 2003-10-30 2005-05-12 Sysmex Corporation 子宮腺癌の診断薬及び腺癌細胞の検出方法
AU2004298392A1 (en) * 2003-12-19 2005-06-30 Keratec Limited Wound care products containing keratin
US7579317B2 (en) * 2005-03-11 2009-08-25 Keratec, Ltd. Nutraceutical composition comprising soluble keratin or derivative thereof
EP2064552B1 (de) * 2006-09-07 2011-08-31 Universitätsklinikum Hamburg-Eppendorf Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen
WO2008070091A1 (en) * 2006-12-06 2008-06-12 Keratec, Ltd. Bone void fillers and methods of making the same
EP2099437A4 (de) * 2006-12-11 2013-06-19 Keratec Ltd Poröses keratin-konstrukt und herstellungsverfahren dafür
WO2008148109A1 (en) * 2007-05-24 2008-12-04 Keratec, Ltd. Porous keratin constructs, wound healing assemblies and methods using the same
KR20100129262A (ko) * 2007-10-31 2010-12-08 케라텍, 리미티드 케라틴 유도체 및 이의 제조 방법
US11090394B1 (en) 2012-03-27 2021-08-17 Florida A&M University Modified nanodelivery system and method for enhanced in vivo medical and preclinical imaging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150149A (en) * 1976-11-29 1979-04-17 Professional Staff Association Of The Los Angeles County Harbor General Hospital Method and means for the early detection and diagnosis of certain types of cancers
US4229426A (en) * 1978-02-22 1980-10-21 Duke University, Inc. Breast cyst fluid protein assay
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
CA1190853A (en) * 1981-10-13 1985-07-23 Roberto L. Ceriani Method and compositions for carcinoma diagnosis
CA1215331A (en) * 1983-03-04 1986-12-16 Tsann M. Chu Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy

Also Published As

Publication number Publication date
EP0167616B1 (de) 1995-07-26
EP0167616A4 (de) 1986-09-04
US4775620A (en) 1988-10-04
JP2723203B2 (ja) 1998-03-09
DE3588043T2 (de) 1996-03-21
JPH0681760B2 (ja) 1994-10-19
JPS6452800A (en) 1989-02-28
JPH08275778A (ja) 1996-10-22
CA1336171C (en) 1995-07-04
JPH10123138A (ja) 1998-05-15
ATE125626T1 (de) 1995-08-15
EP0167616A1 (de) 1986-01-15
JP2537539B2 (ja) 1996-09-25
JP2896362B2 (ja) 1999-05-31
WO1985003132A1 (en) 1985-07-18
JPS6447392A (en) 1989-02-21
JP2617289B2 (ja) 1997-06-04
JPS61501048A (ja) 1986-05-22

Similar Documents

Publication Publication Date Title
ATE125626T1 (de) Cytokeratin-tumormarkierer und test zu deren nachweis.
BR9916207A (pt) Composições e métodos para terapia e diagnósticode câncer ovariano
PL366575A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka jajnika
NO163986C (no) Fremgangsmaate for in vitro bedoemmelse av muligheten for cellekreft.
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
BR0008709A (pt) Método para diagnosticar diferencialmente emonitorar carcinomas malignos de mama
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
BR0009608A (pt) Compostos para imunoterapia e diagnóstico de câncer de mama e métodos para sua utilização
AU555699B2 (en) Pp13 protein from placenta
ES2101695T3 (es) Haptoglobina relacionada con el cancer (hpr).
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
ATE71225T1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
Kitaoka et al. Alpha-fetoprotein content in tissues from patients with gastric cancer
Tosca et al. Antigenic alterations in tumors of epidermal origin
JPS5686194A (en) Novel protein and its manufacture
ATE475710T1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
ES538403A0 (es) Procedimiento para la obtencion de antipodas opticos del (+7-1,7-difenil-3-metilaza-7-ciano-8-metil-nonano
ATE61734T1 (de) Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
DK496683A (da) Diagnostisk proeve for reumatologiske sygdomme
DE3070210D1 (en) A process for preparing tumor antidotes (oncoclasines) from the excrements of goats
IT7830722A0 (it) Metodo di prova in vitro per la diagnosi di tumori maligni.
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings